Loading clinical trials...
Loading clinical trials...
The purpose of this study to evaluate the potential for disease-mediated drug-drug interactions between cendakimab and selected substrates of metabolic enzymes in eosinophilic esophagitis participants...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Celgene
NCT02504853 · Food Allergy, Loeys-Dietz Syndrome, and more
NCT07112378 · Eosinophilic Esophagitis (EoE)
NCT06693531 · Eosinophilic Esophagitis (EoE)
NCT05199532 · Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, and more
NCT06596252 · Eosinophilic Esophagitis
Local Institution - 004
Tucson, Arizona
Local Institution - 001
Los Angeles, California
Local Institution - 022
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions